Cargando…
Commentary: Biosimilars in the treatment of retinopathy of prematurity
Autores principales: | Soni, Tanvi, Kohli, Piyush |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10228922/ https://www.ncbi.nlm.nih.gov/pubmed/36727330 http://dx.doi.org/10.4103/ijo.IJO_2254_22 |
Ejemplares similares
-
Commentary: Simulators for vitreoretinal surgical training
por: Soni, Tanvi, et al.
Publicado: (2022) -
Commentary: Expanding the horizons of red-free examination
por: Soni, Tanvi, et al.
Publicado: (2022) -
Commentary: Scleral penetration or perforation during strabismus surgery
por: Soni, Tanvi, et al.
Publicado: (2023) -
Commentary: Shifting our focus to diabetic retinopathy is the need of the hour
por: Kohli, Piyush, et al.
Publicado: (2022) -
Efficacy of a biosimilar ranibizumab monotherapy for the treatment of retinopathy of prematurity
por: Prajapati, Vipul, et al.
Publicado: (2023)